Honoring Dr. James P. Smith: A tribute to his contributions to LCAP, his enduring legacy in medical screening practices, and his family.

This study indicates that comprehensive lifestyle modifications can significantly reduce cardiovascular risk factors.

Experts at RSNA 2024 discuss AI's transformative impact on cardiovascular imaging, featuring insights from HeartLung.AI., Nurea, AI4MedImagi

Dr. Cheryl Healton, DrPH, emphasizes AI's role in public health, expanding lung screening, and managing smoking-related illnesses.

Panel highlights advanced imaging and AI in early disease detection, emphasizing standardized reporting and insurance for preventive measure

Dr. Susan K. Fried, PhD, highlights how sex and race differences in visceral fat impact cardiovascular disease and diabetes risk.

HeartLung Technologies welcomes Dr. Robert A. Kloner to the Advisory Board. Discover his contributions to heart health and his music.

Dr. Jeffrey Mechanick, MD, redefines abnormal adiposity, linking ectopic fat to cardiometabolic diseases and urging lifestyle changes.

USPSTF endorses DEXA for osteoporosis. HeartLung's AutoBMD™ offers a safer, radiation-free alternative.

Dr. Mingqian Huang, MD, emphasizes the critical role of advanced imaging and AI in detecting and managing osteoporosis and sarcopenia.

Dr. Andrea D. Branch, PhD, highlights CT screening for liver steatosis, a metabolic syndrome marker, and the role of new drugs in treatment.

2024 was a monumental year for HeartLung Technologies. With that being said, we have exciting developments for 2025!

Experts in pulmonary medicine stress the early detection of lung diseases, low-dose CT scans, and the role of pulmonologists in patient care

Dr. Metersky stresses the importance of early bronchiectasis diagnosis and treatment, noting the benefits of low-dose CT scans and more.

Dr. Maria Padilla, MD, stresses early ILD diagnosis, highlighting low-dose CT scans for better outcomes and new therapeutic interventions.

Dr. Rizzo stresses the need for early COPD detection, clear guidelines, and the role of pulmonologists and new drugs in improving outcomes.

Dr. Mulshine highlights early detection's role in preventing thoracic disease deaths, advocating for screening effectiveness over quantity.

Experts discuss integrating lung cancer screening with cardiovascular prevention using AI and low-dose CT scans to enhance early detection.

Dr. Sharma stresses the need for early detection and transcatheter procedures for valvular heart disease, noting higher prevalence in women.

Dr. Reddy highlights AF's rising prevalence and risks, stressing early detection and anticoagulation to reduce stroke in high-risk patients.